CME Group's Financials for Q4 and Full-Year of 2022 Hit Record

CME Group​, the world's leading derivatives marketplace, released its financial results for the fourth quarter and full year of 2022, showing that the group had its best year last year and best Q4 ever. This was due to global market participants turned to the group to navigate tremendous economic and geopolitical uncertainty, according to Terry Duffy, CME Group Chairman and Chief Executive Officer.

For Q4, the group achieved record average daily volume (ADV) of 21.8 million contracts, up 6% compared to the prior year's Q4. This was driven by double-digit growth in equity index and foreign exchange. In the quarter, the revenue stood at $1.2 billion and operating income of $668 million, rising 9% and 57% on a yearly basis, respectively. Net income came in at $638 million and diluted earnings per common share at $1.75, both up 2%. On an adjusted basis, net income was $698 million and diluted earnings per common share were $1.92. 

For the full year 2022, the group generated a 19% yearly increase in ADV to a record 23.3 million contracts. Total revenues recorded $5.0 billion and operating income was $3.0 billion, increasing 6% and 15% year-over-year, respectively. Net income was $2.7 billion and diluted earnings per common share were $7.40, up 4% and 2%. On an adjusted basis, net income was $2.9 billion, and diluted earnings per common share were $7.97.